BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schaapman JJ, Tushuizen ME, Coenraad MJ, Lamb HJ. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. J Magn Reson Imaging 2021;53:1623-31. [PMID: 32822095 DOI: 10.1002/jmri.27292] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Poker A, Karcaaltıncaba M, Ozmen MN, Karaosmanoğlu AD, Erdemir AG, Ocal O, Akata D, Idilman IS. Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. Insights Imaging 2022;13:147. [PMID: 36064860 DOI: 10.1186/s13244-022-01281-w] [Reference Citation Analysis]
2 Jyothi P, Singh AR. Deep learning models and traditional automated techniques for brain tumor segmentation in MRI: a review. Artif Intell Rev. [DOI: 10.1007/s10462-022-10245-x] [Reference Citation Analysis]
3 Gjela M, Askeland A, Frøkjær JB, Mellergaard M, Handberg A. MRI-based quantification of renal fat in obese individuals using different image analysis approaches. Abdom Radiol (NY) 2022. [PMID: 35849166 DOI: 10.1007/s00261-022-03603-4] [Reference Citation Analysis]
4 Dillman JR, Benoit SW, Gandhi DB, Trout AT, Tkach JA, VandenHeuvel K, Devarajan P. Multiparametric quantitative renal MRI in children and young adults: comparison between healthy individuals and patients with chronic kidney disease. Abdom Radiol (NY) 2022;47:1840-52. [PMID: 35237897 DOI: 10.1007/s00261-022-03456-x] [Reference Citation Analysis]
5 Rijnberg FM, Westenberg JJM, van Assen HC, Juffermans JF, Kroft LJM, van den Boogaard PJ, Terol Espinosa de Los Monteros C, Warmerdam EG, Leiner T, Grotenhuis HB, Jongbloed MRM, Hazekamp MG, Roest AAW, Lamb HJ. 4D flow cardiovascular magnetic resonance derived energetics in the Fontan circulation correlate with exercise capacity and CMR-derived liver fibrosis/congestion. J Cardiovasc Magn Reson 2022;24:21. [PMID: 35346249 DOI: 10.1186/s12968-022-00854-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zou L, Jiang J, Zhang H, Zhong W, Xiao M, Xin S, Wang Y, Xing W. Comparing and combining MRE, T1ρ, SWI, IVIM, and DCE-MRI for the staging of liver fibrosis in rabbits: Assessment of a predictive model based on multiparametric MRI. Magn Reson Med 2021. [PMID: 34931716 DOI: 10.1002/mrm.29126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Maier L, von Krüchten R, Lorbeer R, Filler J, Nattenmüller J, Thorand B, Koenig W, Rathmann W, Bamberg F, Schlett CL, Peters A, Rospleszcz S. Distribution and Associated Factors of Hepatic Iron-A Population-Based Imaging Study. Metabolites 2021;11:871. [PMID: 34940629 DOI: 10.3390/metabo11120871] [Reference Citation Analysis]
8 Cao JY, Artunduaga M, Schooler GR. Hepatic manifestations of systemic disease: an imaging-based review. Pediatr Radiol 2021. [PMID: 34797394 DOI: 10.1007/s00247-021-05222-5] [Reference Citation Analysis]
9 Velasco C, Cruz G, Jaubert O, Lavin B, Botnar RM, Prieto C. Simultaneous comprehensive liver T1 , T2 , T 2 , T , and fat fraction characterization with MR fingerprinting. Magn Reson Med 2021. [PMID: 34792212 DOI: 10.1002/mrm.29089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D, Woodward E, Korenjak M, Willemse J, Koek GH, Vinker S, Ungan M, Mendive JM, Lionis C. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep 2021;3:100322. [PMID: 34693236 DOI: 10.1016/j.jhepr.2021.100322] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
11 Maier L, von Krüchten R, Lorbeer R, Filler J, Nattenmüller J, Thorand B, Koenig W, Rathmann W, Bamberg F, Schlett CL, Peters A, Rospleszcz S. Distribution and associated factors of hepatic iron – a population-based imaging study.. [DOI: 10.1101/2021.10.11.21264730] [Reference Citation Analysis]
12 Sorino P, Campanella A, Bonfiglio C, Mirizzi A, Franco I, Bianco A, Caruso MG, Misciagna G, Aballay LR, Buongiorno C, Liuzzi R, Cisternino AM, Notarnicola M, Chiloiro M, Fallucchi F, Pascoschi G, Osella AR. Development and validation of a neural network for NAFLD diagnosis. Sci Rep 2021;11:20240. [PMID: 34642390 DOI: 10.1038/s41598-021-99400-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 McKay A, Pantoja C, Hall R, Matthews S, Spalding P, Banerjee R. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. J Patient Rep Outcomes 2021;5:89. [PMID: 34508298 DOI: 10.1186/s41687-021-00363-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chan E, Kelly M, Schnabel JA. Comparison of Classical Machine Learning & Deep Learning to Characterise Fibrosis & Inflammation Using Quantitative MRI. 2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI) 2021. [DOI: 10.1109/isbi48211.2021.9433962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Venkatesh SK, Miller FH. Reply to "Multiparametric MRI in patients with nonalcoholic fatty liver disease". J Magn Reson Imaging 2021;53:1940. [PMID: 33452704 DOI: 10.1002/jmri.27511] [Reference Citation Analysis]
16 Schaapman JJ, Coenraad MJ, Lamb HJ. Response to letter: Multiparametric magnetic resonance imaging in patients with nonalcoholic fatty liver disease. J Magn Reson Imaging 2021;53:1941. [PMID: 33438298 DOI: 10.1002/jmri.27510] [Reference Citation Analysis]
17 Tonev D, Shumbayawonda E, Tetlow LA, Herdman L, French M, Rymell S, Thomaides-Brears H, Caseiro-Alves F, Castelo-Branco M, Ferreira C, Coenraad M, Lamb H, Beer M, Kelly M, Banerjee R, Dollinger M; RADIcAL1. The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial. JMIR Res Protoc 2020;9:e19189. [PMID: 33104014 DOI: 10.2196/19189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]